Clinical Trials Browser

Withdrawn × IFL protocol × Gastrointestinal × Clear all

NCT07323576 2026-02-09

INAVO-CRC

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT04270929 2021-06-01

PANC-001

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT01605344 2014-02-27

Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI

Phase 1 Withdrawn

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms